Global Antibody Discovery Market Size is predicted to expand and reach USD 6.434 Billion by 2035 | CAGR of 12.39 %

Global Antibody Discovery Market Size is predicted to expand and reach USD 6.434 Billion by 2035.

According to a research report published by Spherical Insights & Consulting, the Global Antibody Discovery Market size is anticipated to grow from USD 1.781 billion in 2024 to USD 6.434 billion by 2035, at a CAGR of 12.39% during the forecast period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the Global Antibody Discovery Market Size, Share, and COVID-19 Impact Analysis, By Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody Drug Conjugates, Immunoconjugates, and Others), By Nature (Human Antibodies, Humanized Antibodies, Chimeric Antibodies, and Murine Antibodies), By End User (In-House Players, Contract Research Organizations, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. " Detailed Report Decription Here : https://www.sphericalinsights.com/reports/antibody-discovery-market
 

The antibody discovery market refers to the sector focused on the identification, optimization, and development of novel antibodies for therapeutic, diagnostic, and research applications using technologies such as phage display, hybridoma, single B-cell screening, and AI-driven platforms. The market is primarily driven by factors such as the rising prevalence of chronic and infectious diseases, increasing demand for targeted biologics, technological advancements in high-throughput and AI-enabled discovery platforms, and growing investments by pharmaceutical and biotechnology companies. However, market growth is restrained by high R&D costs, complex regulatory requirements, long development timelines, and challenges in translating preclinical antibody candidates into clinically viable therapeutics.

The monoclonal antibodies segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the antibody discovery market is divided into monoclonal antibodies, bispecific antibodies, antibody drug conjugates, immunoconjugates, and others. Among these, the monoclonal antibodies segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The monoclonal antibodies segment dominated market growth due to strong therapeutic effects against cancer and infectious diseases while delivering precise treatment results and achieving multiple FDA approvals through its successful clinical outcomes and its high throughput screening methods and developed targeted therapies.

The human antibodies segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the nature, the antibody discovery market is divided into human antibodies, humanized antibodies, chimeric antibodies, and murine antibodies. Among these, the human antibodies segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The human antibodies segment led market growth due to safety profile which exceeds that of non-human and chimeric options and its targeted oncology and immunology treatment capabilities.

The in-house players segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the antibody discovery market is divided into in-house players, contract research organizations, and others. Among these, the in-house players segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The in-house players segment market growth is due to increased capacity to maintain total control over intellectual property rights while their development timelines have been shortened through their capacity to create clinical connections from discovery work and their expertise in antibody engineering.

North America is expected to hold the majority share of the global antibody discovery market during the forecast period.

North America is expected to hold the majority share of the global antibody discovery market during the forecast period. North America is expected grow in the global antibody discovery market due to multiple major pharmaceutical and biotechnology companies that develop and research antibodies. The combination of governmental and private funding organizations together with a supportive regulatory framework enables organizations to conduct research and develop novel biologic technologies at an accelerated pace.

Asia Pacific is anticipated to grow at the fastest pace in the global antibody discovery market during the forecast period. Asia Pacific is expected to grow rapidly in the antibody discovery market due to major pharmaceutical and biotechnology research centers which create demand for advanced antibody discovery services. The region experiences strong growth because both chronic diseases are becoming more common and new antibody-based therapeutic products are entering development.

Major vendors in the global antibody discovery market include WuXi Biologics, Genmab, Adimab, Thermo Fisher Scientific, Charles River Laboratories, Twist Bioscience, AbCellera Biologics, Harbour BioMed, Evotec, ImmunoPrecise Antibodies, Creative Biolabs, Lonza Group, Biocytogen, FairJourney Biologics, Aragen Life Sciences, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Developments

• In March 2026, Biocytogen Pharmaceuticals announced a partnership with Moonlight Bio, Inc. to leverage its fully human antibody library and discovery platforms to develop advanced cell therapies targeting hard-to-treat cancers.

• In January 2026, Harbour BioMed exercised warrants and strengthened its collaboration with Spruce Biosciences to support the discovery and development of next-generation antibody therapeutics across immunology and oncology.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the antibody discovery market based on the below-mentioned segments:

Global Antibody Discovery Market, By Type

• Monoclonal Antibodies
• Bispecific Antibodies
• Antibody Drug Conjugates
• Immunconjugates
• Others

Global Antibody Discovery Market, By Nature

• Human Antibodies
• Humanized Antibodies
• Chimeric Antibodies
• Murine Antibodies

Global Antibody Discovery Market, By End User

• In-House Players
• Contract Research Organizations
• Others

Global Antibody Discovery Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter